237 related articles for article (PubMed ID: 27372421)
41. A shell-crosslinked polymeric micelle system for pH/redox dual stimuli-triggered DOX on-demand release and enhanced antitumor activity.
Wang L; Zhang J; Song M; Tian B; Li K; Liang Y; Han J; Wu Z
Colloids Surf B Biointerfaces; 2017 Apr; 152():1-11. PubMed ID: 28063272
[TBL] [Abstract][Full Text] [Related]
42. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
43. Acetate ions enhance load and stability of doxorubicin onto PEGylated nanodiamond for selective tumor intracellular controlled release and therapy.
Li L; Tian L; Zhao W; Li Y; Yang B
Integr Biol (Camb); 2016 Sep; 8(9):956-67. PubMed ID: 27502159
[TBL] [Abstract][Full Text] [Related]
44. Bioreducible core-crosslinked hyaluronic acid micelle for targeted cancer therapy.
Han HS; Choi KY; Ko H; Jeon J; Saravanakumar G; Suh YD; Lee DS; Park JH
J Control Release; 2015 Feb; 200():158-66. PubMed ID: 25550153
[TBL] [Abstract][Full Text] [Related]
45. Exogenous vitamin C triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency.
Zhu Y; He Y; Su T; Li C; Cai S; Wu Z; Huang D; Zhang X; Cao J; He B
J Mater Chem B; 2020 Jun; 8(23):5109-5116. PubMed ID: 32412025
[TBL] [Abstract][Full Text] [Related]
46. The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles.
Attia AB; Yang C; Tan JP; Gao S; Williams DF; Hedrick JL; Yang YY
Biomaterials; 2013 Apr; 34(12):3132-40. PubMed ID: 23380357
[TBL] [Abstract][Full Text] [Related]
47. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer.
Xiao K; Li YP; Wang C; Ahmad S; Vu M; Kuma K; Cheng YQ; Lam KS
Biomaterials; 2015 Oct; 67():183-93. PubMed ID: 26218744
[TBL] [Abstract][Full Text] [Related]
48. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
49. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs.
Hong G; Yuan R; Liang B; Shen J; Yang X; Shuai X
Biomed Microdevices; 2008 Oct; 10(5):693-700. PubMed ID: 18350380
[TBL] [Abstract][Full Text] [Related]
50. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
[TBL] [Abstract][Full Text] [Related]
51. Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin.
Xu Y; Meng F; Cheng R; Zhong Z
Macromol Biosci; 2009 Dec; 9(12):1254-61. PubMed ID: 19904724
[TBL] [Abstract][Full Text] [Related]
52. Polymeric micelles with dual thermal and reactive oxygen species (ROS)-responsiveness for inflammatory cancer cell delivery.
Tang M; Hu P; Zheng Q; Tirelli N; Yang X; Wang Z; Wang Y; Tang Q; He Y
J Nanobiotechnology; 2017 May; 15(1):39. PubMed ID: 28511687
[TBL] [Abstract][Full Text] [Related]
53. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X
Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838
[TBL] [Abstract][Full Text] [Related]
54. Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery.
Leong J; Chin W; Ke X; Gao S; Kong H; Hedrick JL; Yang YY
Nanomedicine; 2018 Nov; 14(8):2666-2677. PubMed ID: 30017961
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery.
Rongbin H; Lei X; Ying L; Xiangping D; Xuan C; Lanfang L; Cuiyun Y; Yanming C; Guotao T
J Pharm Pharmacol; 2016 Jun; 68(6):751-61. PubMed ID: 27018539
[TBL] [Abstract][Full Text] [Related]
56. Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy.
Saw PE; Yu M; Choi M; Lee E; Jon S; Farokhzad OC
Biomaterials; 2017 Apr; 123():118-126. PubMed ID: 28167390
[TBL] [Abstract][Full Text] [Related]
57. Reduction-sensitive micelles with sheddable PEG shells self-assembled from a Y-shaped amphiphilic polymer for intracellular doxorubicine release.
Cui C; Yu P; Wu M; Zhang Y; Liu L; Wu B; Wang CX; Zhuo RX; Huang SW
Colloids Surf B Biointerfaces; 2015 May; 129():137-45. PubMed ID: 25843367
[TBL] [Abstract][Full Text] [Related]
58. [The characterisitics of temperature/pH sensitive block copolymer micelles in vitro].
Jia L; Qiao MX; Hu HY; Zhao XL; Chen DW
Yao Xue Xue Bao; 2011 Jul; 46(7):839-44. PubMed ID: 22010355
[TBL] [Abstract][Full Text] [Related]
59. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.
Jin Y; Song L; Su Y; Zhu L; Pang Y; Qiu F; Tong G; Yan D; Zhu B; Zhu X
Biomacromolecules; 2011 Oct; 12(10):3460-8. PubMed ID: 21863891
[TBL] [Abstract][Full Text] [Related]
60. Galactoxyloglucan-modified nanocarriers of doxorubicin for improved tumor-targeted drug delivery with minimal toxicity.
Joseph MM; Aravind SR; George SK; Pillai KR; Mini S; Sreelekha TT
J Biomed Nanotechnol; 2014 Nov; 10(11):3253-68. PubMed ID: 26000385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
